Zai Lab Financials
| ZLAB Stock | USD 33.91 0.96 2.91% |
Zai |
Understanding current and past Zai Lab Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Zai Lab's financial statements are interrelated, with each one affecting the others. For example, an increase in Zai Lab's assets may result in an increase in income on the income statement.
Please note, the presentation of Zai Lab's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zai Lab's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Zai Lab's management manipulating its earnings.
Zai Lab Stock Summary
Zai Lab competes with C4 Therapeutics, Erasca, Cullinan Oncology, Legend Biotech, and Alnylam Pharmaceuticals. Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. Zai Lab Limited was incorporated in 2013 and is headquartered in Shanghai, China. Zai Lab operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1951 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US98887Q1040 |
| CUSIP | 98887Q104 |
| Location | China |
| Business Address | Jinchuang Plaza, Shanghai, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.zailaboratory.com |
| Phone | 86 21 6163 2588 |
| Currency | USD - US Dollar |
Zai Lab Key Financial Ratios
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.21 | ||||
| Target Price | 52.03 | ||||
| Beta | 1.02 |
Zai Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Zai Lab's current stock value. Our valuation model uses many indicators to compare Zai Lab value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zai Lab competition to find correlations between indicators driving Zai Lab's intrinsic value. More Info.Zai Lab is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zai Lab's earnings, one of the primary drivers of an investment's value.Zai Lab Systematic Risk
Zai Lab's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Zai Lab volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Zai Lab correlated with the market. If Beta is less than 0 Zai Lab generally moves in the opposite direction as compared to the market. If Zai Lab Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Zai Lab is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Zai Lab is generally in the same direction as the market. If Beta > 1 Zai Lab moves generally in the same direction as, but more than the movement of the benchmark.
About Zai Lab Financials
What exactly are Zai Lab Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Zai Lab's income statement, its balance sheet, and the statement of cash flows. Potential Zai Lab investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Zai Lab investors may use each financial statement separately, they are all related. The changes in Zai Lab's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Zai Lab's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Zai Lab Thematic Clasifications
Zai Lab is part of Cancer Fighters investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Public companies from health care and pharmaceutical sectors that are focused on fighting cancer. Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases
This theme covers Public companies from health care and pharmaceutical sectors that are focused on fighting cancer. Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. Get More Thematic Ideas
| Cancer Fighters | View |
Zai Lab February 26, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Zai Lab help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zai Lab. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zai Lab based on widely used predictive technical indicators. In general, we focus on analyzing Zai Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zai Lab's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.76 | |||
| Information Ratio | 0.1208 | |||
| Maximum Drawdown | 11.46 | |||
| Value At Risk | (5.27) | |||
| Potential Upside | 4.12 |
Complementary Tools for Zai Stock analysis
When running Zai Lab's price analysis, check to measure Zai Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zai Lab is operating at the current time. Most of Zai Lab's value examination focuses on studying past and present price action to predict the probability of Zai Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zai Lab's price. Additionally, you may evaluate how the addition of Zai Lab to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |